Severity
Moderate
FDA Drug recall · Reported April 27, 2016
Chemical Contamination: Potential for contamination of the products with an aromatic hydrocarbon resin.
Hospira Inc. recalled Dextrose Injection, USP, 70%, Packaged as 500 mL in 1000 mL Bag, Rx only, Hospira, Inc.,… - a moderate-severity action.
Dextrose Injection, USP, 70%, Packaged as 500 mL in 1000 mL Bag, Rx only, Hospira, Inc.,… was recalled by Hospira Inc. in April 27, 2016. Reason: Chemical Contamination: Potential for contamination of the products with an aromatic hydrocarbon resin.. Check the official notice for the remedy. Verify recall #D-0827-2016 with the FDA Drug before acting.
The recall
Hospira Inc. issued this moderate-severity FDA Drug recall-Chemical Contamination: Potential for contamination of the products with an aromatic hydrocarbon resin..
Sourced from official FDA Drug enforcement records. Verify recall #D-0827-2016 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Drug action (record #D-0827-2016) was formally reported on April 27, 2016, with the manufacturer initiating the action on March 8, 2016. It is classified under Moderate severity (Class II), with a current status of Terminated. Hospira Inc. is listed as the recalling firm, operating out of Lake Forest, IL. Federal records list the affected scope as 11256 bags.
The documented reason for this recall is: Chemical Contamination: Potential for contamination of the products with an aromatic hydrocarbon resin. Distribution data in the federal record shows the product reached: US: Nationwide and Singapore. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 5 from FDA Drug - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 14,287 drugs & medications recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified moderate severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Moderate
Affected scope
11256 bags
Related Recalls
6
5 from same agency
Dextrose Injection, USP, 70%, Packaged as 500 mL in 1000 mL Bag, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-7918-19, Barcode (01) 0 030409 791819 5
Chemical Contamination: Potential for contamination of the products with an aromatic hydrocarbon resin.
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Moderate (Class II) |
| Status | Terminated |
| Recall number | D-0827-2016 |
| Date reported | April 27, 2016 |
| Date initiated | March 8, 2016 |
| Recalling firm | Hospira Inc. |
| Firm location | Lake Forest, IL |
| Affected scope | 11256 bags |
| Distribution | US: Nationwide and Singapore |
Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
AbbVie Inc. · 2026-06-03
Llorens Pharmaceuticals International Division, Inc. · 2026-05-27
Safecor Health, LLC · 2026-05-27
IntegraDose Compounding Services LLC · 2026-05-27
Lupin Pharmaceuticals Inc. · 2026-05-27
Compare this recall with PRED MILD, prednisolone acetate ophthalmic suspension, USP,… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported April 27, 2016. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.